TrialEBioMedicine2025

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial.

Simone Hoffmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.